CDC-Phase II and III, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of ABBV -47D11 in Out-of-Hospital COVID-19 Adults
COMMERCIAL CLINICAL TRIAL
Clinical trial information
- Promoter: ABBVIE SPAIN SLU
- Phase: III
- Execution start: 22/12/2020
- PI: CARMEN HIDALGO TENORIO